S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
FB   189.55 (+0.35%)
MSFT   140.41 (-0.82%)
GOOGL   1,243.00 (+0.06%)
AMZN   1,777.43 (+0.57%)
CGC   19.73 (-1.84%)
NVDA   194.21 (-1.10%)
MU   45.16 (-2.80%)
BABA   177.12 (+1.04%)
GE   8.90 (+0.11%)
TSLA   259.75 (+0.72%)
AMD   30.81 (+0.29%)
T   37.79 (-0.29%)
F   9.07 (+0.00%)
ACB   3.61 (-3.99%)
PRI   123.87 (+0.16%)
NFLX   286.28 (+0.71%)
BAC   30.17 (+1.48%)
GILD   65.35 (+0.08%)
DIS   130.86 (+0.85%)
S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
FB   189.55 (+0.35%)
MSFT   140.41 (-0.82%)
GOOGL   1,243.00 (+0.06%)
AMZN   1,777.43 (+0.57%)
CGC   19.73 (-1.84%)
NVDA   194.21 (-1.10%)
MU   45.16 (-2.80%)
BABA   177.12 (+1.04%)
GE   8.90 (+0.11%)
TSLA   259.75 (+0.72%)
AMD   30.81 (+0.29%)
T   37.79 (-0.29%)
F   9.07 (+0.00%)
ACB   3.61 (-3.99%)
PRI   123.87 (+0.16%)
NFLX   286.28 (+0.71%)
BAC   30.17 (+1.48%)
GILD   65.35 (+0.08%)
DIS   130.86 (+0.85%)
Log in

Precision BioSciences Stock Price, News & Analysis (NASDAQ:DTIL)

$6.60
-0.27 (-3.93 %)
(As of 10/16/2019 04:00 PM ET)
Today's Range
$6.52
Now: $6.60
$6.92
50-Day Range
$6.71
MA: $8.43
$10.08
52-Week Range
$6.52
Now: $6.60
$19.00
Volume140,646 shs
Average Volume176,884 shs
Market Capitalization$334.16 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Precision BioSciences, Inc. operates as a genome editing company and develops therapeutic products in the United States. It operates through two segments, Therapeutic and Food. The company offers ARCUS, a genome editing platform to cure cancers and genetic disorders. The Therapeutic segment develops allogeneic CAR T immunotherapy that recognizes and kills cancer cells; and engages in the in vivo gene correction activities. This segment develops PBCAR0191, is an allogeneic CAR T cell therapy targeting the tumor target CD19 for acute lymphoblastic leukemia and non-hodgkin lymphoma; and CD20, BCMA, and CLL-1, CAR T cell therapies targeting the tumor antigens. The Food segment develops food and nutrition products; and pre-breeding materials, a gene edited crop intermediate that could be integrated into breeding program and use in producing new crop varieties. The company has development and commercial license agreement with Shire Plc for research and development of individual T cell modifications; collaboration agreement with Gilead Sciences, Inc. to co-develop a product candidate to cure chronic Hepatitis B infection. Precision BioSciences, Inc. was founded in 2006 and is headquartered in Durham, North Carolina.

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:DTIL
CUSIPN/A
CIKN/A
Phone919-314-5512

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$10.88 million

Profitability

Miscellaneous

Employees127
Market Cap$334.16 million
Next Earnings Date11/13/2019 (Estimated)
OptionableNot Optionable

Receive DTIL News and Ratings via Email

Sign-up to receive the latest news and ratings for DTIL and its competitors with MarketBeat's FREE daily newsletter.


Precision BioSciences (NASDAQ:DTIL) Frequently Asked Questions

What is Precision BioSciences' stock symbol?

Precision BioSciences trades on the NASDAQ under the ticker symbol "DTIL."

How were Precision BioSciences' earnings last quarter?

Precision BioSciences Inc (NASDAQ:DTIL) announced its quarterly earnings results on Wednesday, August, 14th. The company reported ($0.39) earnings per share for the quarter, beating the consensus estimate of ($0.47) by $0.08. The company had revenue of $5.39 million for the quarter, compared to analysts' expectations of $8.18 million. View Precision BioSciences' Earnings History.

When is Precision BioSciences' next earnings date?

Precision BioSciences is scheduled to release their next quarterly earnings announcement on Wednesday, November 13th 2019. View Earnings Estimates for Precision BioSciences.

What price target have analysts set for DTIL?

6 analysts have issued 1-year target prices for Precision BioSciences' stock. Their predictions range from $21.00 to $24.00. On average, they anticipate Precision BioSciences' share price to reach $22.80 in the next year. This suggests a possible upside of 245.5% from the stock's current price. View Analyst Price Targets for Precision BioSciences.

What is the consensus analysts' recommendation for Precision BioSciences?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Precision BioSciences in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Precision BioSciences.

Has Precision BioSciences been receiving favorable news coverage?

Media headlines about DTIL stock have been trending positive recently, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Precision BioSciences earned a coverage optimism score of 2.1 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Precision BioSciences.

Are investors shorting Precision BioSciences?

Precision BioSciences saw a increase in short interest in September. As of September 30th, there was short interest totalling 702,200 shares, an increase of 31.0% from the August 30th total of 535,900 shares. Based on an average trading volume of 147,200 shares, the short-interest ratio is presently 4.8 days. Approximately 2.2% of the shares of the company are short sold. View Precision BioSciences' Current Options Chain.

Who are some of Precision BioSciences' key competitors?

What other stocks do shareholders of Precision BioSciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Precision BioSciences investors own include Alibaba Group (BABA), JD.Com (JD), Baidu (BIDU), Micron Technology (MU), CVS Health (CVS), Johnson & Johnson (JNJ), AT&T (T), TENCENT HOLDING/ADR (TCEHY), Cisco Systems (CSCO) and Editas Medicine (EDIT).

Who are Precision BioSciences' key executives?

Precision BioSciences' management team includes the folowing people:
  • Mr. Matthew R. Kane, Co-Founder, CEO, Pres & Director (Age 42)
  • Dr. Derek Jantz Ph.D., Co-founder, Chief Scientific Officer & Director (Age 43)
  • Dr. Jefferson J. Smith Ph.D., Co-Founder & CTO
  • Mr. Abid Ansari, Chief Financial Officer (Age 41)
  • Ms. Molly Lukes PHR, SHRM-CP, Director of HR

When did Precision BioSciences IPO?

(DTIL) raised $126 million in an IPO on Thursday, March 28th 2019. The company issued 7,900,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan, Goldman Sachs, Jefferies and Barclays acted as the underwriters for the IPO.

When did Precision BioSciences' lock-up period expire?

Precision BioSciences' lock-up period expired on Tuesday, September 24th. Precision BioSciences had issued 7,900,000 shares in its public offering on March 28th. The total size of the offering was $126,400,000 based on an initial share price of $16.00. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the end of the lock-up period.

How do I buy shares of Precision BioSciences?

Shares of DTIL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Precision BioSciences' stock price today?

One share of DTIL stock can currently be purchased for approximately $6.60.

How big of a company is Precision BioSciences?

Precision BioSciences has a market capitalization of $334.16 million and generates $10.88 million in revenue each year. Precision BioSciences employs 127 workers across the globe.View Additional Information About Precision BioSciences.

What is Precision BioSciences' official website?

The official website for Precision BioSciences is http://www.precisionbiosciences.com/.

How can I contact Precision BioSciences?

Precision BioSciences' mailing address is 302 EAST PETTIGREW STREET SUITE A-100, DURHAM NC, 27701. The company can be reached via phone at 919-314-5512 or via email at [email protected]


MarketBeat Community Rating for Precision BioSciences (NASDAQ DTIL)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  28 (Vote Outperform)
Underperform Votes:  19 (Vote Underperform)
Total Votes:  47
MarketBeat's community ratings are surveys of what our community members think about Precision BioSciences and other stocks. Vote "Outperform" if you believe DTIL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DTIL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/16/2019 by MarketBeat.com Staff

Featured Article: Is the QQQ ETF safe?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel